These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28304156)

  • 1. Probing the Time Dependency of Cyclooxygenase-1 Inhibitors by Computer Simulations.
    Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
    Biochemistry; 2017 Apr; 56(13):1911-1920. PubMed ID: 28304156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
    Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
    Biochemistry; 2018 Feb; 57(7):1236-1248. PubMed ID: 29345921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of the Enigmatic Stepwise Tight-Binding Inhibition of Cyclooxygenase-1.
    Shamsudin Y; Kazemi M; Gutiérrez-de-Terán H; Åqvist J
    Biochemistry; 2015 Dec; 54(49):7283-91. PubMed ID: 26562384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations.
    Selinsky BS; Gupta K; Sharkey CT; Loll PJ
    Biochemistry; 2001 May; 40(17):5172-80. PubMed ID: 11318639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of kinetic profiles in 2-aryl propionic acid cyclooxygenase inhibitors.
    Gupta K; Kaub CJ; Carey KN; Casillas EG; Selinsky BS; Loll PJ
    Bioorg Med Chem Lett; 2004 Feb; 14(3):667-71. PubMed ID: 14741265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of mammalian cyclooxygenases.
    Garavito RM; Mulichak AM
    Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles.
    Oniga SD; Pacureanu L; Stoica CI; Palage MD; Crăciun A; Rusu LR; Crisan EL; Araniciu C
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28891941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward an optimal docking and free energy calculation scheme in ligand design with application to COX-1 inhibitors.
    Shamsudin Y; Gutiérrez-de-Terán H; Boukharta L; Åqvist J
    J Chem Inf Model; 2014 May; 54(5):1488-99. PubMed ID: 24786949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
    Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
    J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
    Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
    Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.
    Rimon G; Sidhu RS; Lauver DA; Lee JY; Sharma NP; Yuan C; Frieler RA; Trievel RC; Lucchesi BR; Smith WL
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):28-33. PubMed ID: 19955429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sila-Ibuprofen.
    Kleemiss F; Justies A; Duvinage D; Watermann P; Ehrke E; Sugimoto K; Fugel M; Malaspina LA; Dittmer A; Kleemiss T; Puylaert P; King NR; Staubitz A; Tzschentke TM; Dringen R; Grabowsky S; Beckmann J
    J Med Chem; 2020 Nov; 63(21):12614-12622. PubMed ID: 32931274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.
    Pouplana R; Lozano JJ; Pérez C; Ruiz J
    J Comput Aided Mol Des; 2002 Oct; 16(10):683-709. PubMed ID: 12650588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular dynamics simulation, and evaluation of biological activity of novel flurbiprofen and ibuprofen-like compounds.
    Yıldız MT; Osmaniye D; Saglik BN; Levent S; Kurnaz R; Ozkay Y; Kaplancıklı ZA
    J Mol Recognit; 2024 Sep; 37(5):e3089. PubMed ID: 38894531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies.
    Bhardwaj A; Kaur J; Wuest F; Knaus EE
    ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
    Abdel-Aziz AA; ElTahir KE; Asiri YA
    Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic insights into cyclooxygenase irreversible inactivation by aspirin.
    Tosco P; Lazzarato L
    ChemMedChem; 2009 Jun; 4(6):939-45. PubMed ID: 19301318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition.
    Limongelli V; Bonomi M; Marinelli L; Gervasio FL; Cavalli A; Novellino E; Parrinello M
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5411-6. PubMed ID: 20215464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Marnett AB; Crews BC; Remmel RP; Marnett LJ
    J Med Chem; 2000 Jul; 43(15):2860-70. PubMed ID: 10956194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR.
    Viegas A; Manso J; Corvo MC; Marques MM; Cabrita EJ
    J Med Chem; 2011 Dec; 54(24):8555-62. PubMed ID: 22091869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.